PIAS:不只是活化STAT的抑制蛋白

PIAS(protein inhibitor of activated STAT)家族蛋白是作为活化的STAT的转录活性抑制蛋白被发现的,有5个成员,5种PIAS蛋白都具有3个共同的结构域特征,即N端SAP结构域,中间的锌结合模体Zn-RF和C端的富含丝氨酸/苏氨酸区域。现发现PIAS蛋白不但与激活的STAT蛋白相互作用,还与核内激素受体、TGFβ通路的Smad、Wnt通路的LEF1、细胞周期相关的P53等转录因子和HDAC、FAK等非转录因子相互作用,并调节转录因子的活性。PIAS对转录因子活性的调节有正或负调节,这决定于不同的PIAS分子与不同的转录因子的相互作用。随着对PIAS的研究增多,也引发出许多重要问题需待未来研究去回答。     

酵母RNA聚合酶II羧基端结构域激酶CTDK-I及其亚基的结构与功能

RNA聚合酶Ⅱ最大亚基Rpb1的羧基端结构域（carboxyl-terminal repeat domain,CTD）是RNA聚合酶Ⅱ发挥转录延伸功能所必需的,对其执行精确的转录调节功能至关重要。酵母细胞周期蛋白依赖性激酶CTDK-I（carboxyl-terminal repeat domain kinase,CTDK-I）由CTK1、CTK2和CTK3组成,作用于RNA聚合酶Ⅱ羧基端结构域,动态磷酸化CTD的七肽重复序列（YSPTSPS）来调控转录和翻译。酵母中的特异性蛋白CTK3与特殊的细胞周期蛋白CTK2结合形成异二聚体,再与CTDK-I的催化亚基CTK1结合以调节其活性。CTK1作为细胞周期蛋白CDK（cyclin dependent kinase,CDK）的同源蛋白,其结构与功能的研究可拓展人们对CDK蛋白家族的认识;CTK2-CTK3复合物对CTK1调控机制的研究也可为细胞周期蛋白抑制剂的研发提供新的思路。本文简述了酵母CTDK-I的功能特点及其亚基的结构与功能以及亚基间的相互作用,并展望了CTDK-I复合物的研究前景。     

酵母RNA聚合酶Ⅱ羧基端结构域激酶CTDK-Ⅰ及其亚基的结构与功能

RNA聚合酶Ⅱ最大亚基Rpb1的羧基端结构域(carboxyl-terminal repeat domain,CTD)是RNA聚合酶Ⅱ发挥转录延伸功能所必需的,对其执行精确的转录调节功能至关重要。酵母细胞周期蛋白依赖性激酶CTDK-Ⅰ (carboxyl-terminal repeat domain kinase,CTDK-Ⅰ)由CTK1、CTK2和CTK3组成,作用于RNA聚合酶Ⅱ羧基端结构域,动态磷酸化CTD的七肽重复序列(YSPTSPS)来调控转录和翻译。酵母中的特异性蛋白CTK3与特殊的细胞周期蛋白CTK2结合形成异二聚体,再与CTDK-Ⅰ的催化亚基CTK1结合以调节其活性。CTK1作为细胞周期蛋白CDK (cyclin dependent kinase,CDK)的同源蛋白,其结构与功能的研究可拓展人们对CDK蛋白家族的认识;CTK2-CTK3复合物对CTK1调控机制的研究也可为细胞周期蛋白抑制剂的研发提供新的思路。本文简述了酵母CTDK-Ⅰ的功能特点及其亚基的结构与功能以及亚基间的相互作用,并展望了CTDK-Ⅰ复合物的研究前景。     

用酵母双杂交系统检测菠菜叶绿体ATP合酶CF1各亚基间的相互作用

将菠菜叶绿体ATP合酶CF1的5种亚基基因分别插入到质粒pGBT9和pGAD424,双转化入酵母菌株,用酵母双杂交系统检测菠菜叶绿体CF1各亚基间的相互作用.结果显示CF1的5种亚基中,γ与ε亚基有较强的相互作用;α与β,α与ε,β与ε,β与δ亚基间也有稳定的相互作用;γ与δ,δ与ε亚基间有微弱的或短暂的相互作用;而α与γ,α与δ,β与γ等亚基间在酵母双杂交系统中没有相互作用.这些结果有助于研究ATP合酶在催化过程中的结构变化和亚基间的相互关系.     

用于蛋白质间相互作用研究的新型双杂交系统

近年来,一些不依赖于转录因子活性的新型双杂交系统相继建立,如分离的泛素系统、蛋白质片段互补分析、阻遏物重构分析和SOS恢复系统等。同利用转录因子活性的酵母双杂交系统相似,这些方法也利用了一些活性蛋白的结构与功能特点来研究蛋白质间相互作用,这些活性蛋白不是转录因子,但也可在结构上进行分离可通过重构使其生物活性得以恢复。由于这些新型双杂交系统的各自特点,使得它们成为酵母双杂交系统的有益补充和研究蛋白质间相互作用的有力工具。     

酵母PAP1与PHO85激酶复合物对YLR190w的磷酸化

酵母基因Pho85编码一个依赖于细胞周期蛋白 (cyclin)的蛋白激酶 (CDK) ,参与多种调控途径。PHO85功能的多效性归于其相关的细胞周期因子 ,现已经鉴定了 10个与PHO85相关的细胞周期因子 (PCL)。为了筛选PAP1 PHO85激酶复合物的特异底物 ,以PAP1为靶分子 ,利用酵母双杂交 (two hybrid)系统从酵母cDNA文库中克隆到一个与PAP1相互作用的蛋白质因子的基因 ,Ylr190w。Ylr190w编码 491个氨基酸的多肽链。体外翻译的YLR190w与纯化的融合蛋白GST PAP1可以被谷胱甘肽亲和柱共同吸附 ,这表明PAP1与YLR190w在体外也可以结合。用免疫沉淀获得的PAP1 PHO85复合物可以磷酸化在大肠杆菌中表达GST YLR190w ;并受到无机磷浓度影响 :高磷条件时磷酸化程度高 ,低磷条件时磷酸化程度低。它能与酵母细胞内YAF9结合 ,YAF9是人具有转录调控活性蛋白质因子AF9的酵母同源物。YLR190w与YAF9的相互作用受到磷条件影响 ,突变YLR190w蛋白S/TP位点的S和T后 ,它们的相互作用明显减弱 ,且不再受到磷条件影响     

PRAS40与14-3-3蛋白各亚型相互作用的酵母双杂交系统检测

PRAS40是近几年新发现的Akt作用底物,14-3-3结合蛋白。为确定PRAS40与14-3-3蛋白7种亚基间相互作用关系,利用gateway方法构建用于酵母双杂交系统的诱饵质粒pEG-PRAS40及转录激活质粒pJG-PRAS40,将PRAS40和14-3-3各亚型质粒分别作为诱饵蛋白质粒及转录激活质粒共转化酵母细胞EGY48,通过氨基酸营养缺陷生长实验及β-半乳糖苷酶显色反应分析两种蛋白相互作用程度。酶切鉴定证实成功地构建了pEG-PRAS40和pJG-PRAS40质粒,酵母双杂交实验结果显示PRAS40可以和14-3-3亚型tau,beta,zeta及epsilon相结合,epsilon较强,beta和zeta次之,tau较弱。此结果将为深入研究PRAS40与14-3-3蛋白生物学功能及发现药物靶标奠定基础。     

MIP与NFκB关键调节因子NEMO相互作用的初步研究

人类基因MIP是一个2000年克隆得到的抑癌基因。已有研究表明它可以与FASP1、MafF等多个蛋白相互作用,具有参与信号传导、调节基因转录等功能。有关MIP抑制某些肿瘤细胞生长的确切机制目前还不明确。本研究首先以MIP为诱饵基因对人胎盘cDNA文库进行了酵母双杂交筛选,发现了一个新的MIP相互作用蛋白片段——NFκB关键调节因子NEMO（NFκB essential modifier）蛋白的部分片段,     

大眼狮鲈鱼皮肤肿瘤病毒（WDSV）逆转录病毒周期蛋白（OrfA）相互作用蛋白的酵母双杂交筛选

大眼狮鲈鱼皮肤肿瘤(WDS)在秋季发生春季萎缩的季节性生长特点与大眼狮鲈鱼皮肤肿瘤病毒 (WDSV) 辅助基因的表达有关. 其中辅助基因orfA的表达产物OrfA蛋白可能是1个潜在的肿瘤相关因子, OrfA与细胞周期蛋白cyclin A和cyclin D同源,也被称为逆转录病毒周期蛋白（retroviral-cyclin）.为了深入研究OrfA的作用和功能,我们构建了诱饵表达载体pGBKT7-orfA,采用酵母双杂交技术,从HeLa cDNA文库中筛选与其相互的蛋白因子. 通过2轮高强度压力的筛选、β-半乳糖苷酶活性验证、回转验证以及测序分析,最终获得了1个与OrfA相互作用的转录因子E2F5. OrfA C端78个氨基酸的多肽或者缺失C端78个氨基酸的OrfA突变体均不能在酵母双杂交系统中与E2F5相互作用. 这些发现为进一步研究OrfA在肿瘤萎缩中的功能奠定了基础.     

Activation of AMP-activated protein kinase (AMPK) inhibits protein synthesis: a potential strategy to prevent the development of cardiac hypertrophy

A necessary mediator of cardiac myocyte enlargement is protein synthesis, which is controlled, in part, by the highly energy-consuming process of peptide-chain elongation. Recently, AMP-activated protein kinase (AMPK), which is a key regulator of cellular energy homeostasis, has been shown to phosphorylate a number of enzymes involved in the control of protein synthesis. Since AMPK may inhibit protein synthesis via a number of different pathways, it is possible that AMPK is also a key regulator of cardiac hypertrophy. Recent advances linking AMPK and the energy status of the cell to the regulation of protein synthesis and (or) cardiac myocyte hypertrophy will be discussed.     

AMPK：细胞能量中枢

腺苷酸活化蛋白激酶（AMP activated protein kinase,AMPK）是真核细胞中高度保守的丝氨酸／苏氨酸蛋白激酶,以异源三聚体的形式广泛存在于真核生物体内,是细胞的能量感受器,在能量代谢调控中起极其重要的作用。肝激酶B1（LKB1）、Ca^2＋／CaM-依赖蛋白激酶激酶β（CaMKKβ）、AMP／ATP或ADP／ATP比值升高以及诸如运动肌肉收缩等生理刺激均可以激活AMPK,进而调节细胞的能量代谢网络,提高其应对内外环境变化的能力,从而维持细胞水平乃至整个机体的稳定状态。活化的AMPK可以增强分解代谢,抑制合成代谢,上调ATP水平,参与细胞糖代谢、脂肪代谢、蛋白质代谢等能量代谢过程,增加细胞能量储备,应对能量缺乏。同时活化的AMPK参与细胞的生长、增殖、凋亡、自噬等基本生物学过程。AMPK是研究肥胖,糖尿病等能量代谢性疾病的核心。肿瘤细胞存在特殊的能量代谢方式,其发生,生长,转移与能量代谢失衡密切相关。AMPK与肿瘤细胞异常的能量代谢相关,为肿瘤发生、发展机制研究提供新的策略。本文主要探讨AMPK的结构、激活机制、参与的物质能量代谢和细胞的基本生物学过程以及与肿瘤发生的关联。     

Quantification and Proteomic Characterization of β-Hydroxybutyrylation Modification in the Hearts of AMPKα2 Knockout Mice

AMP-activated protein kinase alpha 2 (AMPKα2) regulates energy metabolism, protein synthesis, and glucolipid metabolism myocardial cells. Ketone bodies produced by fatty acid β-oxidation, especially β-hydroxybutyrate, are fatty energy–supplying substances for the heart, brain, and other organs during fasting and long-term exercise. They also regulate metabolic signaling for multiple cellular functions. Lysine β-hydroxybutyrylation (Kbhb) is a β-hydroxybutyrate–mediated protein posttranslational modification. Histone Kbhb has been identified in yeast, mouse, and human cells. However, whether AMPK regulates protein Kbhb is yet unclear. Hence, the present study explored the changes in proteomics and Kbhb modification omics in the hearts of AMPKα2 knockout mice using a comprehensive quantitative proteomic analysis. Based on mass spectrometry (LC-MS/MS) analysis, the number of 1181 Kbhb modified sites in 455 proteins were quantified between AMPKα2 knockout mice and wildtype mice; 244 Kbhb sites in 142 proteins decreased or increased after AMPKα2 knockout (fold change >1.5 or <1/1.5, p < 0.05). The regulation of Kbhb sites in 26 key enzymes of fatty acid degradation and tricarboxylic acid cycle was noted in AMPKα2 knockout mouse cardiomyocytes. These findings, for the first time, identified proteomic features and Kbhb modification of cardiomyocytes after AMPKα2 knockout, suggesting that AMPKα2 regulates energy metabolism by modifying protein Kbhb.     

AMPK:细胞能量中枢

腺苷酸活化蛋白激酶(AMPactivated proteinkinase,AMPK)是真核细胞中高度保守的丝氨酸/苏氨酸蛋白激酶,以异源三聚体的形式广泛存在于真核生物体内,是细胞的能量感受器,在能量代谢调控中起极其重要的作用。肝激酶B1(LKB1)、Ca2+/CaM-依赖蛋白激酶激酶β(CaMKKβ)、AMP/ATP或ADP/ATP比值升高以及诸如运动肌肉收缩等生理刺激均可以激活AMPK,进而调节细胞的能量代谢网络,提高其应对内外环境变化的能力,从而维持细胞水平乃至整个机体的稳定状态。活化的AMPK可以增强分解代谢,抑制合成代谢,上调ATP水平,参与细胞糖代谢、脂肪代谢、蛋白质代谢等能量代谢过程,增加细胞能量储备,应对能量缺乏。同时活化的AMPK参与细胞的生长、增殖、凋亡、自噬等基本生物学过程。AMPK是研究肥胖,糖尿病等能量代谢性疾病的核心。肿瘤细胞存在特殊的能量代谢方式,其发生,生长,转移与能量代谢失衡密切相关。AMPK与肿瘤细胞异常的能量代谢相关,为肿瘤发生、发展机制研究提供新的策略。本文主要探讨AMPK的结构、激活机制、参与的物质能量代谢和细胞的基本生物学过程以及与肿瘤发生的关联。     

A preferred AMPK phosphorylation site adjacent to the inhibitory loop of cardiac and skeletal troponin I

5'-AMP-activated protein kinase (AMPK) is a serine/threonine protein kinase that is activated when cellular AMP to ATP ratios rise, potentially serving as a key regulator of cellular energetics. Among the known targets of AMPK are catabolic and anabolic enzymes, but little is known about the ability of this kinase to phosphorylate myofilament proteins and thereby regulating the contractile apparatus of striated muscles. Here, we demonstrate that troponin I isoforms of cardiac (cTnI) and fast skeletal (fsTnI) muscles are readily phosphorylated by AMPK. For cTnI, two highly conserved serine residues were identified as AMPK sites using a combination of high-resolution top-down electron capture dissociation mass spectrometry, (32) P-incorporation, synthetic peptides, phospho-specific antibodies, and site-directed mutagenesis. These AMPK sites in cTnI were Ser149 adjacent to the inhibitory loop and Ser22 in the cardiac-specific N-terminal extension, at the level of cTnI peptides, the intact cTnI subunit, whole cardiac troponin complexes and skinned cardiomyocytes. Phosphorylation time-course experiments revealed that Ser149 was the preferred site, because it was phosphorylated 12-16-fold faster than Ser22 in cTnI. Ser117 in fsTnI, analogous to Ser149 in cTnI, was phosphorylated with similar kinetics as cTnI Ser149. Hence, the master energy-sensing protein AMPK emerges as a possibly important regulator of cardiac and skeletal contractility via phosphorylation of a preferred site adjacent to the inhibitory loop of the thin filament protein TnI.     

Ligand-regulated peptide aptamers that inhibit the 5'-AMP-activated protein kinase

In an effort to extend the peptide aptamer approach, we have developed a scaffold protein that allows small molecule ligand control over the presentation of a peptide aptamer. This scaffold, a fusion of three protein domains, FKBP12, FRB, and GST, presents a peptide linker region for target protein binding only in the absence of the small molecule Rapamycin or other non-immunosuppressive Rapamycin derivatives. Here we describe the characterization of ligand-regulated peptide aptamers that interact with and inhibit the 5'-AMP-activated protein kinase (AMPK). AMPK, a central regulator of cellular energy homeostasis, responds to high cellular AMP/ATP ratios by promoting energy producing pathways and inhibiting energy consuming biosynthetic pathways. We have characterized 15 LiRPs of similar, poly-basic sequence and have determined that they interact with the substrate peptide binding region of both AMPK alpha1 and alpha2. These proteins, some of which serve as poor substrates of AMPK, inhibit the kinase as pseudosubstrates in a Rapamycin-regulated fashion in vitro, an effect that is largely competitive with substrate peptide and mediated by an increase in the kinase's apparent K(m) for substrate peptide. This pseudosubstrate inhibition of AMPK by LiRP proteins reduced the AMP stimulation of AMPK in vitro and caused the inhibited state of the kinase to kinetically resemble the basal, unstimulated state of AMPK, providing potential insight into the molecular mechanisms of AMP stimulation of AMPK.     

Role of AMP-activated protein kinase in the regulation of gene transcription

AMP-activated protein kinase (AMPK) is a regulator of cellular metabolism in response to changes in the energy status of the cells. AMPK was known to shut down energy-consuming pathways in response to a fall in the ATP/AMP ratio by phosphorylating key enzymes of intermediate metabolism. Here we will discuss the recent evidence implicating AMPK in the regulation of gene expression in mammals, mainly in the liver and in the pancreatic beta-cells.     

腺苷酸活化蛋白激酶：肿瘤治疗新靶点

腺苷酸活化蛋白激酶（AMP—activated proteinkinase,AMPK）是真核细胞内发现的一类与细胞能量代谢有关激酶家族中的一员,被称之为“能量感应器”。当细胞内AMP／ATP值升高时,AMPK被激活。研究发现,在肿瘤细胞中,活化的AMPK可协同相关抑癌因子调节细胞周期、细胞凋亡以及蛋白质合成,最终影响细胞的增殖。因而,AMPK可以通过感应细胞能量水平的变化来调节细胞增殖。这给肿瘤治疗提供了一定的启示,即以肿瘤细胞能量代谢特点而探寻抑制肿瘤细胞增殖的途径。     

Developmental Profiles of Lipogenic Enzymes and Their Regulators in the Neonatal Mouse Brain

It has been shown that lipogenic enzymes, such as fatty acid synthase (FAS) and acetyl-CoA carboxylase (ACC), are highly expressed in the rodent brain during the early neonatal period and decline thereafter. However, cellular localization of these enzymes is unknown. Presently, we examined developmental changes in the levels and cellular localization of FAS and ACC, and their putative regulators, sterol-regulatory element-binding protein (SREBP)-1 and AMP-activated protein kinase (AMPK) in the mouse brain. Levels of these proteins including phosphorylated forms of ACC and AMPK decreased between postnatal day 4 (P4) and P19. Immunohistochemical studies indicated that FAS, ACC, AMPK, and SREBP-1 were expressed in neurons at P7, while FAS was found mostly in cells of oligodendrocyte lineage at P19. These studies suggest that neurons in the early neonatal brain are involved in do novo fatty acid synthesis.